DUBLIN--(BUSINESS WIRE)--The "Radiodermatitis - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to the publisher, the Global Radiodermatitis Market is accounted for $318.9 million in 2017 and expected to grow at a CAGR of 4.8% to reach $489.8 million by 2026.
Factor such as the large size of patient pool, increasing obesity, unhealthy habits like usage of tobacco and increasing demand for radiation-based chemotherapy are fueling the market growth. Discovery of equipment of radiation therapies such as intensity-modulated radiation therapy (IMRT) and proton therapy are hindering the market growth.
By distribution channel, Retail pharmacy which provides prescription drugs, among other products and has many customers depending on them because of its features like easy availability and affordability. It has the capability of controlling the stock on hands, participation in pharmacy benefit management (PBM) networks, advising the customers to buy the drugs & suggest prescriptions and having better financial & debt management with the customer are the driving factors for the consumers to depend on retail pharmacy stores.
Based on product, the topical product has key benefits such as reduce the risk of microbial transmission, protect the skin against abrasive materials, easy application, availability, are considered to be the major factors resulting in adoption of these products. Corticosteroids, hydrophilic creams, and topical antibiotics are some of the major products under this segment. Corticosteroids agents are considered as a better standard in the treatment of inflammatory skin conditions, thereby increasing in adoption for the treatment of radiodermatitis.
- ConvaTec Inc.
- Stratpharma AG
- BMG Pharma S.R.L.
- Derma Sciences, Inc.
- Smith & Nephew plc
- Intermed Pharmaceuticals
- Molnlycke Health Care AB
Key Topics Covered:
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Radiodermatitis Market, By Distribution Channel
6 Global Radiodermatitis Market, By Product
7 Global Radiodermatitis Market, By Geography
8 Key Developments
9 Company Profiling
For more information about this report visit https://www.researchandmarkets.com/research/tk4fh3/global?w=4